
Joaquín Almunia, Vice-President of the EC in charge of Competition, gave a press conference announcing the EC decision to impose fines to Lundbeck and other pharma companies for delaying market entry of generic medicines. (EC Audiovisual Services, 19/6/2013)
Discover more from The European Sting - Critical News & Insights on European Politics, Economy, Foreign Affairs, Business & Technology - europeansting.com
Subscribe to get the latest posts sent to your email.






































Why don't you drop your comment here?